The case for Ozempic as a dementia buster is building.
Researchers in Ireland led the study, a review of the existing evidence.
Other scientists and pharmaceutical companies have already begun to test these drugs in clinical trials for dementia prevention.
Semaglutide (the active ingredient in Ozempic and Wegovy) is commonly used to treat type 2 diabetes and obesity.© Starmarpro via Shutterstock
The findings are not the first to suggest a potential dementia-buffering effect from GLP-1 therapy.
Another reviewpublishedlast year also concluded that GLP-1 drugs may have possible metabolic and neuroprotective benefits in people with Alzheimers.
It also remains to be seen how impactful this protective effect will really be, if it is genuine.
So soon enough, well hopefully have some concrete answers to these questions.
News from the future, delivered to your present.
You May Also Like
Trump Is Promising to Lower Drug Prices.
Does Ozempic Really Cause Thyroid Cancer?
Does Ozempic Raise Suicide Risk?
